Published in J Hum Hypertens on January 16, 2014
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med (2008) 5.89
The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) Arch Intern Med (1993) 5.08
The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med (2001) 4.94
Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int (2007) 4.74
Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study. Crit Care Med (2009) 4.30
Hypertensive emergencies. Lancet (2000) 3.96
Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J (2009) 3.52
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis (2008) 2.85
Acute kidney injury and cardiovascular outcomes in acute severe hypertension. Circulation (2010) 2.76
New biomarkers of acute kidney injury. Crit Care Med (2008) 2.11
Hypertensive crises: challenges and management. Chest (2007) 2.06
Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail (2009) 1.75
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J (2009) 1.71
Treatment of hypertensive crisis. N Engl J Med (1990) 1.63
Angiotensin converting enzyme DD genotype is associated with hypertensive crisis. Crit Care Med (2002) 1.53
Endothelial dysfunction: methods of assessment and application to hypertension. Curr Pharm Des (2004) 1.10
Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol (2001) 1.08
Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens (1995) 1.05
Neutrophil gelatinase-associated lipocalin. Curr Opin Crit Care (2010) 1.00
The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. Am J Hypertens (2007) 0.96
Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail (2009) 0.95
Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology (Carlton) (2008) 0.94
Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul Study. Am J Hypertens (2006) 0.93
Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens (2001) 0.92
Pathophysiological events leading to the end-organ effects of acute hypertension. Am J Emerg Med (1985) 0.89
Hypertensive heart failure: patient characteristics, treatment, and outcomes. Am J Emerg Med (2010) 0.89
Current diagnosis and management of hypertensive emergency. Semin Dial (2006) 0.89
Contrasting effects of intervention with ETA and ETB receptor antagonists in hypertension induced by angiotensin II and high-salt diet. Can J Physiol Pharmacol (2010) 0.81
Malignant hypertensive crisis induced by chronic intrarenal norepinephrine infusion. Hypertension (1984) 0.79
Acute hypertensive pulmonary edema: a new paradigm. Can J Physiol Pharmacol (2010) 0.79
Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis. J Hum Hypertens (2012) 0.78
Hypertensive emergencies and urgencies: pathophysiology and clinical aspects. Am Heart J (1986) 0.76
Racial differences in endotoxin-induced tissue factor-triggered coagulation. J Thromb Haemost (2009) 0.93
Influence of the Duffy antigen on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1, CCL-2) in vivo. Int J Immunopathol Pharmacol (2009) 0.80
Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans. Sci Rep (2016) 0.80
Cerebral and Peripheral Metabolism to Predict Successful Reperfusion After Cardiac Arrest in Rats: A Microdialysis Study. Neurocrit Care (2016) 0.76
Biometry of the corpus callosum assessed by 3D ultrasound and its correlation to neurodevelopmental outcome in very low birth weight infants. J Perinatol (2016) 0.75
Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib. Leukemia (2016) 0.75
Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia. J Thromb Haemost (2016) 0.75
Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs. J Thromb Haemost (2016) 0.75
Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjects. J Thromb Haemost (2016) 0.75
Establishment of a low dose canine endotoxemia model to test anti-inflammatory drugs: effects of prednisolone. Int J Immunopathol Pharmacol (2013) 0.75
Anti-C1s Monoclonal Antibody BIVV009 in Late Antibody-Mediated Kidney Allograft Rejection - Results from a First-in-Patient Phase 1 Trial. Am J Transplant (2017) 0.75